Abstract: In one embodiment, a method for preventing and/or treating a virus infection contains administering a type I and/or type III interferon production promoter including Clostridium butyricum or a culture thereof to a subject in need thereof. In another embodiment, a method for promoting production of an interferon contains administering an effective amount of Clostridium butyricum or a culture thereof to a subject.

Abstract: A user authentication apparatus includes a photographing unit which photographs a two-dimensional code displayed on a user authentication support terminal, wherein the two-dimensional code is formed by encoding at least first identification information that uniquely identifies the user, and second identification information that uniquely identifies all user authentication performed using the user authentication support terminal collectively, into the two-dimensional code, an authentication factor acquisition unit which acquires an authentication factor, a decoding unit which acquires the first identification information and the second identification information by decoding the two-dimensional code, a first identification information inquiry unit which inquires as to an existence of the first identification information by referring to a storage unit, a second identification information collation unit which, when the inquiry issued by the first identification information inquiry unit is successful, reads from t

Abstract: The present invention provides a therapeutic or prophylactic agent for HTLV-1-associated myelopathy (HAM), comprising an RGMa-inhibiting substance, and a method for treating HTLV-1-associated myelopathy (HAM), comprising administering a pharmacologically effective amount of an RGMa-inhibiting substance to an HAM patient in need thereof.

Abstract: A user authentication apparatus includes a photographing unit which photographs a two-dimensional code displayed on a user authentication support terminal, wherein the two-dimensional code is formed by encoding at least first identification information that uniquely identifies the user, and second identification information that uniquely identifies all user authentication performed using the user authentication support terminal collectively, into the two-dimensional code, an authentication factor acquisition unit which acquires an authentication factor, a decoding unit which acquires the first identification information and the second identification information by decoding the two-dimensional code, a first identification information inquiry unit which inquires as to an existence of the first identification information by referring to a storage unit, a second identification information collation unit which, when the inquiry issued by the first identification information inquiry unit is successful, reads from t

Abstract: The present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing a compound having a specific chemical structure or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing, as an active ingredient, 7-chloro-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof, or 7-bromo-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing a compound having a specific chemical structure or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing, as an active ingredient, 7-chloro-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof, or 7-bromo-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof.

Abstract: Annotation methods and systems for supporting the annotation of documents in the format of a rendering engine are provided. The annotation system allows for the adding of annotations to documents, the displaying of annotations over content of the documents, and the displaying of annotations in an annotation pane. To provide annotation support for a document, the annotation system augments the document with elements including an element with annotation engine code and elements to support the collecting and displaying of annotations. When the rendering engine renders the document, it executes the annotation engine code to effect the collecting and displaying of the annotations.

Abstract: The ear speaker device includes a mount section that is provided with ear-hook sections, and rotation sections that rotate speaker movable sections with respect to the mount section. Tubular ducts are positioned more inside than the ear-hook sections in a natural state. When the ear speaker device is mounted, the speaker movable sections are rotated to the most outside positions. Then, the ear-hook sections are brought into contact with auricle base upper sections, respectively, and the speaker movable sections are rotated inwardly. In this manner, the tubular ducts can be positioned in the vicinity of the external acoustic meatus openings, respectively, of the listener without interfering with auricles and the like.

Abstract: A solution monitoring system is provided for gathering, filtering, and analyzing information associated with solutions for managing monitoring, upgrades, and migrations. Telemetry may be recorded for various types of solution events and various properties of solutions as part of an add-in intelligence. Furthermore, add-in management tools are provided for administrators and end users.

Abstract: A technology which improves frequency characteristics by an acoustic method so that, when a sound-isolating earphone is attached to a human ear, the sound is heard with natural frequency characteristics is provided. In a sound path from a diaphragm of an electro-acoustic transducer inside a sound-isolating earphone to the eardrum passing through a cylindrical sound leading pipe via the external auditory canal, two independent paths for sound waves are provided in the sound leading pipe, and transfer of the sound with a specific frequency is suppressed by adjusting a difference in length of the paths, whereby the frequency characteristics of the sound passing through this sound path are improved.

Abstract: The ear speaker device includes a mount section that is provided with ear-hook sections, and rotation sections that rotate speaker movable sections with respect to the mount section. Tubular ducts are positioned more inside than the ear-hook sections in a natural state. When the ear speaker device is mounted, the speaker movable sections are rotated to the most outside positions. Then, the ear-hook sections are brought into contact with auricle base upper sections, respectively, and the speaker movable sections are rotated inwardly. In this manner, the tubular ducts can be positioned in the vicinity of the external acoustic meatus openings, respectively, of the listener without interfering with auricles and the like.

Abstract: Provided is a technique for improving frequency characteristics by an acoustics-related method so that a sound is heard with natural frequency characteristics when a sound-isolating earphone is fitted in a human ear. A sound-isolating earphone is provided with two or more electroacoustic transducers, wherein independently generated sound waves are passed through isolated sound leading pipes and are mixed just before an entrance of an external auditory canal, and a sound wave of which is twice the difference between path lengths of the two sound leading pipes is attenuated. This serves to provide an easy-to-hear improved sound quality by suppressing the sound wave at around 6 kHz that is transmitted with characteristically high intensity in a sound-isolating earphone.

Abstract: Provided is a technique for improving frequency characteristics by an acoustics-related method so that a sound is heard with natural frequency characteristics when a sound-isolating earphone is fitted in a human ear. A sound-isolating earphone is provided with two or more electroacoustic transducers, wherein independently generated sound waves are passed through isolated sound leading pipes and are mixed just before an entrance of an external auditory canal, and a sound wave of which is twice the difference between path lengths of the two sound leading pipes is attenuated. This serves to provide an easy-to-hear improved sound quality by suppressing the sound wave at around 6 kHz that is transmitted with characteristically high intensity in a sound-isolating earphone.

Abstract: An ear speaker device includes an electroacoustic transducer including a housing mounted at a predetermined position of listener's head, a speaker unit mounted on one surface in the housing, and positioned away from an entrance of the listener's external acoustic meatus for a predetermined distance when the housing is mounted on the listener's head, and a tubular duct extended so as to allow a sound generated by the housing in the inner space thereof to reach the vicinity of the entrance of the listener's external acoustic meatus, and a hole for emitting sound of the duct is oriented to the opposite direction with respect to the entrance of the external acoustic meatus; and a mounting part used for mounting the electroacoustic transducer on the listener's head in a manner that the predetermined distance is provided between the speaker unit and the entrance of the listener's external acoustic meatus.

Abstract: A solution monitoring system is provided for gathering, filtering, and analyzing information associated with solutions for managing monitoring, upgrades, and migrations. Telemetry may be recorded for various types of solution events and various properties of solutions as part of an add-in intelligence. Furthermore, add-in management tools are provided for administrators and end users.

Abstract: An object is to provide a corium cooling structure that is capable of accumulating corium and debris that have flowed out from a reactor in small divided portions and of sufficiently cooling the high-temperature corium and debris, a reactor containment vessel provided with the same, and a nuclear power plant provided with the same. A capture portion that captures the corium that has flowed out from a reactor and a plurality of pipe portions that are provided in a coolant storing portion and into which the corium flows via the capture portion are provided.

Abstract: A speaker apparatus includes a speaker, a tubular duct extended in order to make the sound generated in the inside of the cabinet of the speaker get to the vicinity of the listener's ears and a support mechanism that rotatably supports the tubular duct in order to bring the front end aperture of the tubular duct to the vicinity of the ears of the listener.

Abstract: A technology which improves frequency characteristics by an acoustic method so that, when a sound-isolating earphone is attached to a human ear, the sound is heard with natural frequency characteristics is provided. In a sound path from a diaphragm of an electro-acoustic transducer inside a sound-isolating earphone to the eardrum passing through a cylindrical sound leading pipe via the external auditory canal, two independent paths for sound waves are provided in the sound leading pipe, and transfer of the sound with a specific frequency is suppressed by adjusting a difference in length of the paths, whereby the frequency characteristics of the sound passing through this sound path are improved.

Abstract: An ear speaker device includes an electroacoustic transducer including a housing mounted at a predetermined position of listener's head, a speaker unit mounted on one surface in the housing, and positioned away from an entrance of the listener's external acoustic meatus for a predetermined distance when the housing is mounted on the listener's head, and a tubular duct extended so as to allow a sound generated by the housing in the inner space thereof to reach the vicinity of the entrance of the listener's external acoustic meatus, and a hole for emitting sound of the duct is oriented to the opposite direction with respect to the entrance of the external acoustic meatus; and a mounting part used for mounting the electroacoustic transducer on the listener's head in a manner that the predetermined distance is provided between the speaker unit and the entrance of the listener's external acoustic meatus.

Abstract: A reproduced sound of high quality is allowed to be listened to by a listener while natural sound image localization is provided. By providing a housing 4L having internal space mounted at a predetermined position of the head of the listener, a speaker unit 7L mounted on one surface of the housing 4L and positioned away from an entrance of an external acoustic meatus of the listener for a predetermined distance when the housing 4L is mounted on the head 100 of the listener, and a tubular duct 8L extended so as to allow a sound generated by the housing 4L to reach the vicinity of the entrance of the external acoustic meatus of the listener, the sound generated by the housing 4L can be directly reached to an eardrum 103L in the inside of the external acoustic meatus from the vicinity of the entrance of the external acoustic meatus of the listener via a tubular duct 8L.